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Abstract
In contrast to the mitochondrial proton-translocating NADH^quinone oxidoreductase (complex I), which consists of at
least 43 different subunits, the internal rotenone-insensitive NADH^quinone oxidoreductase (Ndi1) of Saccharomyces
cerevisiae is a single polypeptide enzyme. The NDI1 gene was stably transfected into the human embryonal kidney 293 (HEK
293) cells. The transfected NDI1 gene was then transcribed and translated in the HEK 293 cells to produce the functional
enzyme. The immunochemical and immunofluorescence analyses indicated that the expressed Ndi1 polypeptide was located
to the inner mitochondrial membranes. The expression of Ndi1 did not alter the content of existing complex I in the HEK
293 mitochondria, suggesting that the expressed Ndi1 enzyme does not displace the endogenous complex I. The NADH
oxidase activity of the NDI1-transfected HEK 293 cells was not affected by rotenone but was inhibited by flavone. The ADP/
O ratios coupled to NADH oxidation were lowered from 2.4 to 1.8 by NDI1-transfection while the ADP/O ratios coupled to
succinate oxidation (1.6) were not changed. The NDI1-transfected HEK 293 cells were able to grow in media containing a
complex I inhibitor such as rotenone and 1-methyl-4-phenylpyridinium ion. The potential usefulness of incorporating the
Ndi1 protein into mitochondria of human cells is discussed. ß 1999 Elsevier Science B.V. All rights reserved.
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Abbreviations: Q, quinone; UQ10, ubiquinone-10; complex I, the mitochondrial proton-translocating NADH-Q oxidoreductase;
NDH-1, the bacterial proton-translocating NADH-Q oxidoreductase; NDH-2, the bacterial NADH-Q oxidoreductase lacking the energy
coupling site; EPR, electron paramagnetic resonance; Ndi1, internal rotenone-insensitive NADH-Q oxidoreductase of S. cerevisiae
mitochondria; MPP, 1-methyl-4-phenylpyridinium ion; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; FP and IP, £avoprotein
and iron^sulfur protein fractions of complex I; ROS, reactive oxygen species; SOD, superoxide dismutase; EGTA, ethylene glycol-bis-
(L-aminoethyl ether)N,N,NP,NP-tetraacetate; Hepes, N-2-hydroxyethylpiperazine-NP-2-ethanesulfonic acid; PMSF, phenylmethylsulfonyl
£uoride; DMEM, Dulbecco’s modi¢ed Eagle’s medium; SDS, sodium dodecyl sulfate; SDS^PAGE, SDS^polyacrylamide gel electro-
phoresis ; HEK, human embryonic kidney; ORF, open reading frame; ECL, enhanced chemiluminescence
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1. Introduction
The NADH^quinone (NADH-Q) oxidoreductase
of the respiratory chains can be divided into three
groups [1^3]. They are the proton-translocating
NADH-Q oxidoreductase (designated complex I in
mitochondria and NDH-1 in bacteria) [1,3], the
Na-translocating NADH-Q oxidoreductase (this
type of enzyme complex has been reported in bacte-
ria only) [4^8], and the NADH-Q oxidoreductase
lacking an energy coupling site [1,3]. Mammalian
mitochondria are believed to contain only complex
I as the NADH dehydrogenase in the respiratory
chain. It is generally accepted that mammalian com-
plex I is composed of at least 43 unlike subunits and
has the most intricate structure of the membrane-
associated enzyme complexes [2,9^12]. Of these 43
subunits, seven are encoded by mitochondrial DNA
and the others are encoded by nuclear DNA [13,14].
Complex I bears noncovalently bound FMN and at
least eight iron^sulfur clusters as prosthetic groups
[15,16]. At the present time, at least ¢ve EPR-detect-
able iron^sulfur clusters have been identi¢ed [9,10].
This enzyme complex is sensitive to rotenone, pieri-
cidin A, rolliniastatin, and capsaicin [17,18]. Com-
plex I has been shown to be a one-electron reaction
enzyme [19]. In contrast to mammalian mitochon-
dria, mitochondria of Saccharomyces cerevisiae lack
complex I but instead have two rotenone-insensitive
NADH-Q oxidoreductases [20^22]. These two
NADH-Q oxidoreductases in S. cerevisiae do not
function as proton-translocating enzymes; one faces
the intermembrane space (referred to as external ro-
tenone-insensitive NADH-Q oxidoreductase). The
other, like the mammalian complex I, faces the mi-
tochondrial matrix (designated internal rotenone-in-
sensitive NADH-Q oxidoreductase (Ndi1)) [20^22].
The Ndi1 enzyme of S. cerevisiae mitochondria is
a single polypeptide enzyme with noncovalently
bound FAD as a cofactor and no iron^sulfur clusters
[20]. The S. cerevisiae Ndi1 is inhibited by £avone
but not by rotenone [1,3,20]. Because neither FADH
intermediates nor semi-quinone EPR signals have
been detected in the Ndi1 enzyme [20], it has been
suggested that, unlike complex I, the Ndi1 enzyme is
a two-electron reaction enzyme. The NDI1 gene en-
coding the enzyme has been cloned and sequenced
[22]. The DNA sequence reveals the presence of an
ORF of 1539 bp predicted to encode a precursor
protein of 513 amino acid residues, which includes
the NH2 terminal 26-residue signal sequence for im-
port into mitochondria. These 26 residues are cleaved
o¡ to form the mature protein [22] which is attached
to the inner mitochondrial membrane on the matrix
side.
As we have recently reported [23,24], S. cerevisiae
Ndi1 is a versatile enzyme as demonstrated by the
fact that the Ndi1 enzyme expressed in Escherichia
coli acts as a member of the respiratory chain in the
prokaryotic host cells. Furthermore, the Ndi1 en-
zyme expressed in complex I-de¢cient Chinese ham-
ster cells restores the NADH oxidase activity to the
parent cell level. These studies suggest that the NDI1
gene may provide a potentially useful tool for gene
therapy of mitochondrial diseases caused by complex
I de¢ciency. As the next step to explore this poten-
tial, it was imperative to verify that the NDI1 gene
could be functionally expressed in mitochondria of
human cells bearing their own inherent complex I. It
would be of particular interest to investigate the fol-
lowing: (a) whether the expressed Ndi1 displaces
complex I in the inner mitochondrial membranes;
(b) whether the expression of the Ndi1 in human cells
modulates the oxidative phosphorylation in host cell
mitochondria (e.g., ADP/O ratios, rotenone sensitiv-
ity, etc.) ; and (c) whether the expressed Ndi1 enzyme
protects cells against free radical complications re-
sulting from complex I catalyzing a one-electron re-
action. This latter point is of interest because it is
known that free radicals are generated by mamma-
lian mitochondrial respiratory chain activity at 1^2%
of all electrons passing down the electron transport
chain [25].
In this paper, we demonstrate that the S. cerevisiae
NDI1 gene can be transcribed and translated in hu-
man embryonal kidney 293 cells. The expressed Ndi1
was incorporated predominantly into mitochondria
which was not unexpected given the presence of the
leader sequence in the precursor Ndi1. In addition,
the expressed enzyme modi¢ed the characteristics of
oxidative phosphorylation in the host cells, although
the content of complex I in HEK 293 mitochondria
was unchanged by NDI1 transfection. The NADH
oxidase activity of Ndi1-overexpressed cells was in-
sensitive to rotenone, but sensitive to £avone. The
ADP/O ratios of oxidative phosphorylation sus-
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tained by the NADH oxidase activity in the trans-
fected HEK 293 cell mitochondria were decreased
from 2.4 to 1.8 owing to the NDI1 overexpression,
whereas the Ndi1 overexpression did not a¡ect the
ADP/O ratios (1.6) associated with succinate oxida-
tion. Finally, although the nontransfected HEK 293
cells could not survive in media containing rotenone
or 1-methyl-4-phenylpyridinium ion (MPP), the
NDI1-transfected cells were resistant to these re-
agents.
2. Materials and methods
2.1. Construction of NDI1-expression plasmid
A 5.5 kbp KpnI/PstI DNA fragment bearing the
full-length NDI1 was excised from the V 7056 (ap-
proximately 17 kbp S. cerevisiae DNA inserted) and
ligated into a KpnI/PstI-cut cloning vector pTZ19U.
The resulting plasmid was designated pKP5.5. A
2.3 kbp SalI/EcoRV fragment, again containing the
full-length NDI1, was then isolated from pKP5.5 and
ligated into a SalI/SmaI-cut cloning vector pTZ18U.
The resulting plasmid was designated pRVS2.3. Two
oligonucleotide primers were employed. One was to
generate a KpnI recognition site 60 bp upstream from
the initiation codon of the NDI1 gene: 5P-TCAGG-
TAGGGTACCAGTT-3P (the underlined bases repre-
sent variations from the S. cerevisiae DNA, and
italicized bases indicate the KpnI site). The other
primer was to construct a BglII site 213 bp down-
stream from the termination codon of the NDI1
gene: 5P-AGTGATCAACAGATCTTG-3P (the under-
lined bases were mutated from S. cerevisiae DNA,
and italicized bases represent the BglII site). Using
pRVS2.3 as the template, site-speci¢c mutagenesis
was carried out [23]. The resulting plasmid was des-
ignated pRVS(KpnI, BglII). The pRVS(KpnI, BglII)
construct was cut with KpnI and BglII, and the
1.9 kbp KpnI/BglII fragment containing the full-
length NDI1 gene (1539 bp) was ligated into the
KpnI/BamHI site in the mammalian expression vec-
tor pHook-2 (Invitrogen). The pHook-2 uses the
Rous sarcoma virus promoter to express and display
a single-chain antibody against a speci¢c hapten on
the surface of transfected cells. The pHook-2 also
contains the human immediate early cytomegalovirus
promoter in the upstream region of a multiple clon-
ing site to express the gene of interest. This plasmid
is useful for both transient and stable transfection.
The resulting expression plasmid was designated
pHook(NDI1). The construct was veri¢ed by DNA
sequencing of both strands as described previously
[24].
2.2. NDI1 gene transfection
The 293 cells of human embryonal kidney was
grown in DMEM supplemented with 10% horse se-
rum, 5 mM galactose, and 50 Wg/ml gentamycin.
Cells were maintained at 37‡C in a 5% CO2 atmo-
sphere.
The HEK 293 cells (1U105) in 1 ml of DMEM
containing 5 mM galactose and 10% horse serum
were transfected with 8^10 Wg of pHook(NDI1) by
the calcium phosphate precipitation method [26]. The
transfected cell lines were isolated by screening with
0.5 mg/ml of antibiotic G418 and 0.1 WM rotenone.
Approximately 10 cell lines were isolated. The iso-
lated cell lines exhibited various levels of NDI1 ex-
pression. Five cell lines indicated high levels of NDI1
expression. These selected cell lines have displayed
the same properties. Of these, one cell line (desig-
nated H47) was used in this paper. One cell line
(designated M49) showed medium level of NDI1 ex-
pression. This cell line was also used in this paper.
The NDI1-transfected HEK 293 cells were grown in
DMEM+10% horse serum+0.5 mg/ml G418+0.1 WM
rotenone in the presence of 5 mM galactose.
2.3. Isolation of mitochondria and mitochondrial
membrane fraction
Mitochondria were isolated from freshly harvested
cells essentially according to Trounce et al. [27]. The
nontransfected and NDI1-transfected HEK 293 cells
(approximately 1U109 cells) were washed twice with
phosphate-bu¡ered saline (PBS) and harvested by
trypsinization. The pellets were suspended in 5 ml
of a bu¡er containing 210 mM mannitol, 70 mM
sucrose, 1 mM EGTA, 5 mM Hepes (pH 7.2), 0.2
mM PMSF, and 0.5% fatty acid free bovine serum
albumin (isolation bu¡er). The cell suspensions were
treated with 1^2 mg/ml of digitonin for 1 min on ice.
The digitonin-treated suspension was then diluted
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10-fold with isolation bu¡er and centrifuged at
3000Ug for 5 min to remove excess detergent. The
cell pellet was resuspended with the isolation bu¡er
and homogenized using a tight ¢tting Dounce ho-
mogenizer (15^20 up/down strokes). The homoge-
nate was centrifuged at 10 000Ug for 20 min at
4‡C to separate cell membrane fragments from the
remaining intact organelles. The pellet was sus-
pended in 0.1 ml of the isolation bu¡er and used
as the intact mitochondrial fraction. The intact mi-
tochondria were brie£y sonicated and centrifuged at
150 000Ug for 30 min at 4‡C. The pellets were re-
suspended in 0.1 ml of the isolation bu¡er and used
as the mitochondrial membrane fraction.
2.4. Digitonin-permeabilized cells
Digitonin, by binding to cholesterol in the eukary-
otic plasma membrane, creates pores through which
the soluble components of the cell can be released
[28]. Because the intracellular membranes have a
cholesterol content substantially lower than the plas-
ma membrane, the mitochondria and the cytoskele-
ton are left intact [29]. Thus, permeabilization with
digitonin allows the mitochondria ready access to the
respiratory substrates and inhibitors (glutamate, suc-
cinate, etc.) to be tested. It should be noted, however,
that in this assay system NADH added exogenously
does not serve as a substrate for complex I because
NADH provided exogenously is present on the cyto-
plasmic side and is unable to penetrate into the mi-
tochondrial matrix. When malate plus glutamate are
employed as respiratory substrates, the correspond-
ing dehydrogenases generate NADH from NAD in
the matrix compartment, which can then be oxidized
by complex I. This assay procedure is reliable and is
not disturbed by various diaphorases.
2.5. Other analytical procedures
Protein was estimated by the bicichoninic acid
(BCA) method (Pierce). SDS^polyacrylamide gel
electrophoresis was carried out by the modi¢ed
method of Laemmli [30]. Immunoblotting [31^33],
measurements of respiratory chain activities by dig-
itonin-permeabilized cells [29] and intact mitochon-
dria [27], and immuno£uorescence [34] were done
according to the references cited. Any variations
from the procedures and other details are described
in the ¢gure legends.
2.6. Materials
Antisera speci¢c to FP 51 kDa, FP 24 kDa, IP 49
kDa, and IP 30 kDa subunits of bovine heart com-
plex I and to L-subunit of bovine F1-ATPase were
generous gifts from Prof. Youssef Hate¢ (The
Scripps Research Institute). Prototype antiserum spe-
ci¢c to human mitochondria was a generous gift
from Prof. Eng M. Tan (The Scripps Research In-
stitute). This serum, from a patient with primary
biliary cirrhosis, reacted with the pyruvate dehydro-
genase complex E2 subunit (70 kDa) and the 55 kDa
polypeptide in human mitochondria. Acrylamide,
N,NP-methylenebis(acrylamide), SDS, SDS^PAGE
calibration marker proteins, Coomassie Brilliant
blue R-250, and the in vitro mutagenesis kit were
from Bio-Rad; NADH, ADP, £avone, rotenone,
and antimycin A were from Sigma; 1-methyl-4-phen-
ylpyridium iodide (MPP) was from Research Bio-
chemicals International (Natick, MA); enhanced
chemiluminescence (ECL) kits were from Amer-
sham; the pHook-2 vector was from Invitrogen.
3. Results
3.1. Expression of the yeast NDI1 in HEK 293 cells
We have previously reported that the yeast NDI1
gene can be functionally overexpressed in E. coli
membranes and that the expressed Ndi1 enzyme sup-
plants the existing NDH-1 and NDH-2 functions in
terms of electron transfer from NADH to Q [23]. In
addition, we demonstrated that the Ndi1 enzyme
could be functionally expressed in complex I-de¢-
cient Chinese hamster CCL16-B2 cells and that the
expressed Ndi1 restored the NADH oxidation activ-
ity in the mitochondria [24]. In order to pursue the
use of the NDI1 gene as a potential therapy for com-
plex I de¢ciency in human mitochondria, it is a pre-
requisite to investigate (a) whether the yeast NDI1
gene can be stably transfected into human cells, (b)
whether the yeast NDI1 gene can be functionally ex-
pressed in human mitochondria, and (c) whether the
expressed Ndi1 can control NADH oxidation in hu-
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man mitochondria. In order to pursue answers to
these questions, we attempted to transfect a HEK
293 cell line with the yeast NDI1 gene. The HEK
293 cell line was selected because it is known to be
e⁄ciently transfected by foreign DNA. Our e¡orts
yielded several stable NDI1-transfected cell lines
which were established from single colonies after se-
lection with the antibiotic G418 and rotenone. Even
after 4 months of culture the transfected cells re-
tained their properties, providing evidence for stable
transfection.
Immuno£uorescence microscopic analyses using
antibodies to human mitochondria and the yeast
Ndi1 polypeptide were employed to identify the lo-
cation of the expressed NDI1 gene product in the
cells. The data indicated that the expressed Ndi1
was predominantly localized in the mitochondria of
the HEK cells. In order to con¢rm these results, the
mitochondrial membranes were isolated from the
NDI1-transfected and nontransfected HEK 293 cells
and were subjected to SDS^PAGE followed by im-
munoblotting with the a⁄nity-puri¢ed antibody to
the yeast NDI1 gene product (Fig. 1). The data in-
dicate that the antibody speci¢c to the yeast Ndi1
enzyme reacted with mitochondria of the transfected
cells but did not react with mitochondria of non-
transfected cells. These data suggest that the leader
sequence of the yeast NDI1 gene successfully guides
Fig. 1. Immunoblotting analyses of mitochondrial membranes
isolated from nontransfected and NDI1-transfected HEK 293
cells, and bovine heart mitochondria by using antibodies specif-
ic to the Ndi1, complex I FP 51 kDa subunit, complex I FP 24
kDa subunit, complex I IP 49 kDa subunit, complex I IP 30
kDa subunit, and the L-subunit of bovine F1-ATPase. The
rightmost lane is the immunoblot of the Ndi1 protein contain-
ing the leader sequence as a standard. The amount of protein
loaded in each lane was adjusted to give similar responses with
respect to the L-subunit of F1 ATPase. Immunoblotting was
performed by use of the ECL system (Amersham).
Fig. 2. Comparison of the NADH oxidase activity of digitonin-
permeabilized nontransfected HEK 293 cells (A), the NDI1-
transfected HEK 293 cells with medium level of expression
(M49) (B), and the NDI1-transfected HEK 293 cells with high
levels of expression (H47) (C) (at 4U107 cells/ml). The cells
were harvested by trypsinization and resuspended in 1 ml of a
medium containing 20 mM Hepes (pH 7.1), 250 mM sucrose,
and 10 mM MgCl2. The cells were treated with 50^150 Wg of
digitonin until more than 90% of the cells are stained by trypan
blue. The digitonin-treated cells were washed with the same me-
dium. Oxygen consumption was measured polarographically in
0.6 ml of the bu¡er containing 20 mM Hepes (pH 7.1), 250
mM sucrose, and 10 mM MgCl2 by using a Clark electrode in
a water-jacketed chamber maintained at 37‡C. Where indicated,
5 mM glutamate (Glu), 5 mM malate (Mal), 5 WM rotenone
(Rot), 0.5 mM £avone (Flavone), 5 mM succinate (Succ), and
5 WM antimycin A (AntA) were added.
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the product to the mitochondria in both human cells
and Chinese hamster cells [24]. Also shown in Fig. 1
is the result of immunoblotting with antibodies di-
rected to the FP 51 kDa, FP 24 kDa, IP 49 kDa and
the IP 30 kDa subunits of bovine heart complex I
[9,10,31,35]. The data reveal that there is no apparent
di¡erence in mitochondria between nontransfected
and the NDI1-transfected 293 cells in terms of the
content of complex I subunits. This is not surprising
because Ndi1-type enzyme and complex I are known
to coexist in plant and certain fungal mitochondria
as well as in bacteria [1,2].
3.2. E¡ect of NDI1 expression on the electron
transport activity
As reported in our previous paper [24], the ex-
pressed yeast Ndi1 enzyme restores the NADH oxi-
dase activity of complex I-de¢cient Chinese hamster
CCL16-B2 cells. Furthermore, in the case of E. coli,
the NADH oxidase activity derived from the ex-
pressed Ndi1 enzyme became signi¢cantly higher
than that of the native NDH-1 and NDH-2 [23].
As described above, the expression of Ndi1 does
not appear to a¡ect the content of complex I in the
mitochondria of HEK 293 cells. Therefore, it was of
interest to investigate the contribution of complex I
and the expressed Ndi1 to the overall electron trans-
port activity of the transfected HEK 293 cells. The
activity measurements were performed using digito-
nin-permeabilized nontransfected and NDI1-trans-
fected HEK 293 cells and the results are shown in
Fig. 2. The nontransfected cells exhibited the ex-
pected malate/glutamate-dependent respiratory activ-
ity, which was completely inhibited by rotenone.
When succinate was added, the respiration was
stimulated. This stimulation was completely inhibited
by antimycin A and KCN. The respiration activity of
the NDI1-transfected cells with medium levels of ex-
pression (M49) induced by malate/glutamate was
partially inhibited by rotenone and then completely
inhibited by addition of £avone. The respiratory ac-
tivity of the NDI1-transfected cells with high levels of
expression (H47) was increased signi¢cantly over
that observed in the nontransfected cells by addition
of malate and glutamate. This increase was not in-
hibited by rotenone, but was inhibited by £avone
[20]. These results indicate that the NADH oxidase
activity observed in the NDI1 expressed HEK 293
cells is ascribed almost entirely to the Ndi1 enzyme
despite the fact that complex I is still present.
NADH, which when added exogenously is unable
Fig. 3. Comparison of ADP/O ratios in nontransfected and
NDI1-transfected (H47) HEK 293 cells using glutamate+malate
and succinate as respiratory substrates. The NDI1-transfected
mitochondria (2.3 mg/ml) and nontransfected mitochondria
(1.7 mg/ml) were prepared as described in Section 2. In panel
A, glutamate+malate were used as respiratory substrates; In
panel B, succinate was used as the respiratory substrate. Gluta-
mate, malate and succinate were added at 5 mM. Where indi-
cated, 50 nmol ADP (pH 7.0) were added. The assay medium
was composed of 225 mM mannitol, 75 mM sucrose, 10 mM
KCl, 10 mM Tris^HCl (pH 7.2), 2.5 mM MgCl2 and 10 mM
KPi (pH 7.2). The oxygraph measurements were carried out as
described in Fig. 2 except that the reaction temperature was
30‡C. The ADP/O ratios determined by the oxygraph analyses
are summarized in the inset table (each ADP/O ratio is an aver-
age of ¢ve experiments).
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to cross the inner mitochondrial membrane, did not
increase the respiration of the digitonin-permeabi-
lized NDI1-transfected HEK 293 cells, suggesting
that the NADH-binding site of the expressed Ndi1
faces the matrix compartment as was observed in the
yeast mitochondria (data not shown) [21]. These re-
sults agree with our previous observations with the
yeast NDI1-transfected Chinese hamster CCL16-B2
mutant cells [24]. To con¢rm that the yeast Ndi1
acts in concert with the other members of the respi-
ratory chain in the HEK 293 cells, the ADP/O ratios
of mitochondria isolated from nontransfected and
NDI1-transfected cells were compared (see Fig. 3).
Because the Ndi1 enzyme lacks an energy coupling
site, if this enzyme is responsible for the NADH to
UQ10 electron transfer, the observed ADP/O ratios
with a NADH-related substrate are expected to be
the same as that with succinate. The data (Fig. 3)
demonstrate that this is, in fact, what was observed.
The ADP/O ratios of nontransfected HEK 293 mi-
tochondria, 2.41 and 1.60 by glutamate/malate and
succinate, respectively, are consistent with previously
reported results [27]. On the other hand, the ADP/O
ratios of the NDI1-transfected HEK 293 (H47) mi-
tochondria were 1.75 and 1.56, respectively, by glu-
tamate/malate and succinate. These results support
the hypothesis that the expressed Ndi1 is capable
of NADH-Q oxidoreductase activity in the respira-
tory chain of HEK 293 mitochondria.
Fig. 5. E¡ect of MPP on cell growth of nontransfected and NDI1-transfected (H47) HEK 293 cells. Nontransfected cells (105) (b)
and NDI1-transfected cells (105) (a) were cultured in a medium containing 0.6 mM glucose, 5 mM galactose, and various concentra-
tions of MPP (0, 0.1, 0.3, and 1.0 mM). 0.5 mg/ml of G418 was added to the NDI1-transfected HEK 293 cell culture medium. Cell
viability and cell numbers were determined as described in Fig. 4.
Fig. 4. E¡ects of rotenone on cell growth of nontransfected and
NDI1-transfected (H47) HEK 293 cells. Both nontransfected
and NDI1-transfected cells (105) were grown in 0.1 WM rote-
none culture medium in the presence of 0.6 mM glucose (a,
transfected; O, nontransfected) or 0.6 mM glucose+5 mM gal-
actose (b, transfected; R, nontransfected). In the case of the
NDI1-transfected HEK 293 cells, 0.5 mg/ml of the antibiotic
G418 also was present. Cells were cultured at 37‡C in a 5%
CO2 atmosphere. Cell viability was assessed by trypan blue ex-
clusion, and cell numbers were determined by using a hemocy-
tometer.
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3.3. E¡ect of rotenone and MPP+ on the cell growth
As anticipated, the NDI1-transfected 293 cells
(H47) can grow in the media containing rotenone
(Fig. 4). This is more evident when oxidative phos-
phorylation was enhanced by the addition of 5 mM
galactose to the growth medium [24]. On the other
hand, the nontransfected cells cannot survive in the
presence of rotenone. The e¡ect of MPP on the
viability of the NDI1-transfected and nontransfected
HEK 293 cells was also examined. MPP is known
to inhibit complex I and to cause Parkinson’s dis-
ease-like symptoms in humans and primates [36].
The data (Fig. 5) reveal that in the culture media
containing 0.1 mM MPP, the NDI1-transfected
cells were able to grow but the nontransfected cells
could not survive. When the concentration of MPP
was increased to 0.3 mM, the NDI1-transfected cells
grew initially and continued to survive for up to
5 days whereas 70% of the nontransfected cells
were dead under the same conditions. At 1.0 mM
MPP, the NDI1-transfected cells survived for up
to 3 days before beginning to die. However, the non-
transfected cells were 70% dead after 1 day of culture
in 1.0 mM MPP, and were completely dead by
3 days in culture. These data clearly indicate that
the NDI1-transfected HEK 293 cells are more insen-
sitive to MPP than the nontransfected HEK 293
cells. This is believed to be due to the fact that
MPP is not a potent inhibitor of the Ndi1 enzyme
expressed in the HEK 293 cells. One possible explan-
ation for the lack of e¡ect of MPP on the Ndi1
enzyme is that the Ndi1 enzyme and complex I cata-
lyze a two-electron reaction and a one-electron reac-
tion, respectively.
4. Discussion
In previous papers [23,24], we have shown that the
S. cerevisiae Ndi1 enzyme can be functionally ex-
pressed and can exhibit NADH-Q oxidoreductase
activity in the respiratory chains of E. coli mem-
branes and complex I-de¢cient Chinese hamster
CCL16-B2 mitochondria. Our ultimate goal is to
use the yeast NDI1 gene to restore the NADH oxi-
dase activity in human mitochondria with complex I
de¢ciency. In this paper, it is demonstrated that the
yeast NDI1 gene can be functionally expressed in the
human embryonic kidney cell line, HEK 293. Despite
the presence of endogenous complex I, the expressed
Ndi1 accounts almost entirely for the electron trans-
fer from NADH to UQ10 in the mitochondria of
these cells. Recently, two respiration-de¢cient Chi-
nese hamster cell mutants have been characterized.
Both were shown to have a mutation in the MWFE
subunit of complex I. One mutant contains a deletion
which produces a truncated MWFE subunit. The
other has a missense mutation which substitutes a
lysine for an arginine at the 50th position. In both
mutant cells, complex I activity was almost entirely
absent. Although complementation of the truncated
MWFE mutant with hamster NDUFA1 cDNA (en-
coding the MWFE subunit) restored the NADH oxi-
dase activity to 100%, complementation of the mis-
sense mutant (R50K) restored the NADH oxidase
activity to only 40% (H.C. Au, B.B. Seo, A. Matsu-
no-Yagi, T. Yagi, I.E. Sche¥er, unpublished results).
These results suggest that under certain conditions
(e.g., point mutation etc.) the defective subunit can
still bind and occupy its site within the enzyme com-
plex, making it di⁄cult to implant the substitute in-
troduced. By contrast, complementation with the
yeast NDI1 gene does not su¡er from this limitation.
As described above, the NDI1-transfected 293 cells
showed NADH oxidase activity which was actually
higher than the nontransfected cells. This is clearly
one of the advantages of using the NDI1 gene as the
rescue gene.
Another advantage of the Ndi1 protein is that it is
believed to catalyze two-electron reactions [20] and
may, thus, alleviate possible complications caused by
reactive oxygen species (ROS). The fact that the
NDI1-transfected cells are much more resistant to
MPP than nontransfected cells supports this hy-
pothesis. Although the actual impact of MPP in
neurotoxicity remains to be demonstrated in living
animals, it has been shown that intracellular MPP
can be taken up and concentrated within the mito-
chondria where it blocks complex I, which in turn
decreases the production of ATP and increases the
formation of free radicals such as superoxide [36].
The role of free radical production in neurotoxicity
has recently been assessed by testing MPTP toxicity
in transgenic mice with increased activity of Cu/Zn-
superoxide dismutase (SOD), the key enzyme in the
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detoxi¢cation of superoxide. These transgenic mice
have 2.5^3 times greater brain SOD activity than
do wild-type animals. MPTP administration was
shown to cause substantial damage in the wild-type
animals. In contrast, no signi¢cant damage was de-
tected in the transgenic animals with increased SOD
[36]. It may be expected that similar results will be
observed in NDI1-transgenic mice. This hypothesis
will be veri¢ed in the future.
The decrease in ADP/O ratio of the mitochondrial
respiratory chain in the transfected cells represents
yet another potential advantage of transfection with
the NDI1 gene. Given the major contribution of
NADH oxidation to the overall ATP synthesis in
mitochondria, the lowered ADP/O ratio should
lead to decreased production of ATP in the cell.
This would make the Ndi1 enzyme a likely therapeu-
tic tool for obesity. One of the possible therapies
currently being considered for obesity is to uncouple
oxidative phosphorylation [37^39]. However, pre-
vious e¡orts to treat obesity by uncoupling oxidative
phosphorylation using thyroid hormone, dinitro-
phenol or massive doses of sympathetic agonists
have failed because mitochondrial uncoupling oc-
curred at unwanted, as well as at desired, sites [37].
It is envisioned that, unlike the use of uncouplers,
with the Ndi1 enzyme it should be easier to attenuate
the level of ATP because it only a¡ects the ¢rst
coupling site of the respiratory chain leaving the
other sites fully functional.
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